Johnson & Johnson
$652M 13F equity value
20 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc. | 2,449,183 | $258M | 39.6% |
| NBTX | Nanobiotix S.A. | 5,623,816 | $174M | 26.6% |
| MGTX | MeiraGTx Holdings plc | 6,641,064 | $58M | 8.8% |
| RAPP | Rapport Therapeutics, Inc. | 1,784,517 | $56M | 8.6% |
| CVRX | CVRx, Inc. | 4,024,861 | $38M | 5.8% |
| CTNM | Contineum Therapeutics Inc. | 1,979,173 | $26M | 4.0% |
| LEGN | Legend Biotech Corporation | 814,586 | $15M | 2.3% |
| XNCR | Xencor, Inc. | 748,062 | $9M | 1.4% |
| PRCT | Procept BioRobotics Corporation | 357,939 | $9M | 1.4% |
| FATE | Fate Therapeutics, Inc. | 3,379,064 | $4M | 0.6% |
Track Johnson & Johnson's 13F portfolio: $652M in reported holdings, 20 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}